1600 John F. Kennedy Boulevard, suite 1020<br>
Philadelphia, Pennsylvania<br>
États-Unis<br>
19103<br>
<b>Adresse Internet : </b><a href="https://www.nrgoncology.org/" target="_blank">https://www.nrgoncology.org/</a><br>
<br>
<table border="0" cellspacing="0" cellpadding="3">
    <tr>
        <td bgcolor="#f1f1f1"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_une.gif" width="15" height="8" border="0">&nbsp;</td>
        <td colspan="2" bgcolor="#f1f1f1"><b>Projet(s) actif(s)</b></td>
    </tr>
    <tr>
        <td bgcolor="#dddddd">&nbsp;</td>
        <td bgcolor="#dddddd"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_deux.gif" width="15" height="8" border="0">&nbsp;</td>
        <td bgcolor="#dddddd">
            <a href="/fileadmin/ulaval_ca/Images/recherche/bd/projet/fiche/140567.html">A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)</a></li>
        </td>
    </tr>
    <tr>
        <td bgcolor="#ffffff">&nbsp;</td>
        <td bgcolor="#ffffff"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_deux.gif" width="15" height="8" border="0">&nbsp;</td>
        <td bgcolor="#ffffff">
            <a href="/fileadmin/ulaval_ca/Images/recherche/bd/projet/fiche/140719.html">A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases</a></li>
        </td>
    </tr>
    <tr>
        <td bgcolor="#dddddd">&nbsp;</td>
        <td bgcolor="#dddddd"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_deux.gif" width="15" height="8" border="0">&nbsp;</td>
        <td bgcolor="#dddddd">
            <a href="/fileadmin/ulaval_ca/Images/recherche/bd/projet/fiche/142970.html">Parallel Phase III Randomized Trials of Genomic-risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-intensification and Intensification Clinical Trial Evaluation (GUIDANCE)</a></li>
        </td>
    </tr>
    <tr>
        <td bgcolor="#ffffff">&nbsp;</td>
        <td bgcolor="#ffffff"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_deux.gif" width="15" height="8" border="0">&nbsp;</td>
        <td bgcolor="#ffffff">
            <a href="/fileadmin/ulaval_ca/Images/recherche/bd/projet/fiche/143368.html">Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) For Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)</a></li>
        </td>
    </tr>
    <tr>
        <td bgcolor="#dddddd">&nbsp;</td>
        <td bgcolor="#dddddd"><img src="/fileadmin/ulaval_ca/Images/recherche/bd/img/fleche_puce_deux.gif" width="15" height="8" border="0">&nbsp;</td>
        <td bgcolor="#dddddd">
            <a href="/fileadmin/ulaval_ca/Images/recherche/bd/projet/fiche/141382.html">The Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer</a></li>
        </td>
    </tr>
</table>